Pre-made Bectumomab benchmark antibody (Fab Fusion, anti-CD22 therapeutic antibody, Anti-SIGLEC-2/SIGLEC2 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Bectumomab benchmark antibody (Fab Fusion, anti-CD22 therapeutic antibody, Anti-SIGLEC-2/SIGLEC2 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Bectumomab (marketed under the trade name LymphoScan) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect non-Hodgkin's lymphoma.[1][2]

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-751-1mg	1mg	3090
GMP-Bios-INN-751-10mg	10mg	Inquiry
GMP-Bios-INN-751-100mg	100mg	Inquiry
GMP-Bios-INN-751-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Bectumomab Biosimilar, Fab Fusion, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody
INN Name	Bectumomab
Target	CD22
Format	Fab Fusion
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	Fab' - G2a - kappa
VD LC	Fab' - G2a - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Immunomedics Inc. (Morris Plains NJ USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0